COVID-19 Diagnostics Market Size, Share, Trends, Growth and Forecast 2026

COVID-19 Diagnostics Market

COVID-19 Diagnostics Market By Product (Instruments, Kits & Reagents, Diagnostic Services), By Technology (Molecular assay, Immunological assay, Digital PCR (dPCR), Clustered regularly interspaced short palindromic repeats (CRISPR), Microarray), By Test Type (Antigen-based Testing, Antibody (Serology) Testing, Molecular (PCR) Testing, Others) By Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC) By End-User (Hospitals, Diagnostic Labs & Clinics, Healthcare Labs & Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5323 Published Date: Mar-2020 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 52.56 Billion USD 145.48 Billion 15.65% 2019

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global COVID-19 Diagnostics Market, 2016 – 2026 (USD Billion)
    • 3.2.Global COVID-19 Diagnostics Market: Snapshot
  • Chapter 4.COVID-19 Diagnostics Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
    • 4.3.Market Restraints
    • 4.4.Market Opportunities
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global COVID-19 Diagnostics Market Attractiveness, By Product
    • 5.2.Global COVID-19 Diagnostics Market Attractiveness, By Technology
    • 5.3.Global COVID-19 Diagnostics Market Attractiveness, By Test Type
    • 5.4.Global COVID-19 Diagnostics Market Attractiveness, By Mode
    • 5.5.Global COVID-19 Diagnostics Market Attractiveness, By End-User
    • 5.6.Global COVID-19 Diagnostics Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global COVID-19 Diagnostics Market: Company Market Share, 2019
    • 6.2.Strategic Developments
  • Chapter 7.COVID-19 Diagnostics Market – Product Segment Analysis
    • 7.1.Global COVID-19 Diagnostics Market Overview: by Product
      • 7.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Product, 2019 & 2026
    • 7.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Product
      • 7.2.1.Instruments – Overview/Analysis
      • 7.2.2.Kits & Reagents – Overview/Analysis
      • 7.2.3.Diagnostic Services– Overview/Analysis
    • 7.3.Instruments
      • 7.3.1.Global COVID-19 Diagnostics Market for Instruments, Revenue (USD Billion) 2016 - 2026
    • 7.4.Kits & Reagents
      • 7.4.1.Global COVID-19 Diagnostics Market for Kits & Reagents, Revenue (USD Billion) 2016 – 2026
    • 7.5.Diagnostic Services
      • 7.5.1.Global COVID-19 Diagnostics Market for Diagnostic Services, Revenue (USD Billion) 2016 – 2026
  • Chapter 8.COVID-19 Diagnostics Market – Technology Segment Analysis
    • 8.1.Global COVID-19 Diagnostics Market Overview: by Technology
      • 8.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Technology, 2019 & 2026
    • 8.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Technology
      • 8.2.1.Mulecular assay – Overview/Analysis
      • 8.2.2.Immunulogical assay – Overview/Analysis
      • 8.2.3.Digital PCR (dPCR) – Overview/Analysis
      • 8.2.4.Clustered regularly interspaced short palindromic repeats (CRISPR) – Overview/Analysis
      • 8.2.5.Microarray– Overview/Analysis
    • 8.3.Mulecular assay
      • 8.3.1.Global COVID-19 Diagnostics Market for Mulecular assay, Revenue (USD Billion) 2016 - 2026
    • 8.4.Immunulogical assay
      • 8.4.1.Global COVID-19 Diagnostics Market for Immunulogical assay, Revenue (USD Billion) 2016 - 2026
    • 8.5.Digital PCR (dPCR)
      • 8.5.1.Global COVID-19 Diagnostics Market for Digital PCR (dPCR), Revenue (USD Billion) 2016 - 2026
    • 8.6.Clustered regularly interspaced short palindromic repeats (CRISPR)
      • 8.6.1.Global COVID-19 Diagnostics Market for Clustered regularly interspaced short palindromic repeats (CRISPR), Revenue (USD Billion) 2016 - 2026
    • 8.7.Microarray
      • 8.7.1.Global COVID-19 Diagnostics Market for Microarray, Revenue (USD Billion) 2016 - 2026
  • Chapter 9.COVID-19 Diagnostics Market – Test Type Segment Analysis
    • 9.1.Global COVID-19 Diagnostics Market Overview: by Test Type
      • 9.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Test Type, 2019 & 2026
    • 9.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Test Type
      • 9.2.1.Antigen-based Testing – Overview/Analysis
      • 9.2.2.Antibody (Serulogy) Testing – Overview/Analysis
      • 9.2.1.Mulecular (PCR) Testing– Overview/Analysis
      • 9.2.2.Others– Overview/Analysis
    • 9.3.Antigen-based Testing
      • 9.3.1.Global COVID-19 Diagnostics Market for Antigen-based Testing, Revenue (USD Billion) 2016 - 2026
    • 9.4.Antibody (Serulogy) Testing
      • 9.4.1.Global COVID-19 Diagnostics Market for Antibody (Serulogy) Testing, Revenue (USD Billion) 2016 - 2026
    • 9.5.Mulecular (PCR) Testing
      • 9.5.1.Global COVID-19 Diagnostics Market for Mulecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
    • 9.5.Others
      • 9.5.1.Global COVID-19 Diagnostics Market for Others, Revenue (USD Billion) 2016 – 2026
  • Chapter 10.COVID-19 Diagnostics Market – Mode Segment Analysis
    • 10.1.Global COVID-19 Diagnostics Market Overview: by Mode
      • 10.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Mode, 2019 & 2026
    • 10.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Mode
      • 10.2.1.Point-of-Care (PoC) – Overview/Analysis
      • 10.2.2.Non-Point-of-Care (Non-PoC)– Overview/Analysis
    • 10.3.Point-of-Care (PoC)
      • 10.3.1.Global COVID-19 Diagnostics Market for Point-of-Care (PoC), Revenue (USD Billion) 2016 - 2026
    • 10.4.Non-PoC
      • 10.4.1.Global COVID-19 Diagnostics Market for Non-PoC, Revenue (USD Billion) 2016 - 2026
  • Chapter 11.COVID-19 Diagnostics Market – End User Segment Analysis
    • 11.1.Global COVID-19 Diagnostics Market Overview: by End User
      • 11.1.1.Global COVID-19 Diagnostics Market Revenue Share, by End User, 2019 & 2026
    • 11.2.Global COVID-19 Diagnostics Market Analysis/Overview – By End User
      • 11.2.1.Hospitals – Overview/Analysis
      • 11.2.2.Diagnostic Labs & Clinics– Overview/Analysis
      • 11.2.1.Healthcare Labs & Clinics– Overview/Analysis
    • 11.3.Hospitals
      • 11.3.1.Global COVID-19 Diagnostics Market for Hospitals, Revenue (USD Billion) 2016 - 2026
    • 11.4.Diagnostic Labs & Clinics
      • 11.4.1.Global COVID-19 Diagnostics Market for Diagnostic Labs & Clinics, Revenue (USD Billion) 2016 - 2026
    • 11.5.Mulecular (PCR) Testing
      • 11.5.1.Global COVID-19 Diagnostics Market for Mulecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
    • 11.5.Healthcare Labs & Clinics
      • 11.5.1.Global COVID-19 Diagnostics Market for Healthcare Labs & Clinics, Revenue (USD Billion) 2016 – 2026
  • Chapter 12.COVID-19 Diagnostics Market – Regional Analysis
    • 12.1.Global COVID-19 Diagnostics Market: Regional Overview
      • 12.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Region, 2019 & 2026
      • 12.1.2.Global COVID-19 Diagnostics Market Revenue, by Region, 2016 – 2026 (USD Billion)
    • 12.2.North America
      • 12.2.1.North America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.2.2.North America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.2.3.North America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.2.4.North America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.2.5.North America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.2.6.North America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.2.7.North America COVID-19 Diagnostics Market Revenue, by End User, 2016 – 2026
      • 12.2.8. U.S.
      • 12.2.9.Canada
    • 12.3.Europe
      • 12.3.1.Europe COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.3.2.Europe COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.3.3.Europe COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.3.4.Europe COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.3.5.Europe COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.3.6.Europe COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.3.7.Europe COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.3.8.Germany
      • 12.3.9.France
      • 12.3.10. U.K.
      • 12.3.11.Rest of Europe
    • 12.4.Asia Pacific
      • 12.4.1.Asia Pacific COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.4.2.Asia Pacific COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.4.3.Asia Pacific COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.4.4.Asia Pacific COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.4.5.Asia Pacific COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.4.6.Asia Pacific COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.4.7.Asia Pacific COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.4.8.China
      • 12.4.9.Japan
      • 12.4.10.India
      • 12.4.11.Rest of Asia Pacific
    • 12.5.Latin America
      • 12.5.1.Latin America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.5.2.Latin America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.5.3.Latin America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.5.4.Latin America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.5.5.Latin America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.5.6.Latin America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.5.7.Latin America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.5.8.Brazil
      • 12.5.9.Mexico
      • 12.5.10.Rest of Latin America
    • 12.6.The Middle-East and Africa
      • 12.6.1.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.6.2.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.6.3.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.6.4.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.6.5.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.6.6.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.6.7.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
  • Chapter 13.Company Profiles
    • 13.1.Aspen Pharmacare Hulding, Ltd.
    • 13.2.Hulogic Inc.
    • 13.3.Perkin Elmer, Inc.
    • 13.4.Veredus Laboratories
    • 13.5.Thermo Fisher Scientific, Inc.
    • 13.6. F. Hoffman-La Roche Ltd.
    • 13.7.1drop Inc.
    • 13.8.Laboratory Corporation of America Huldings
    • 13.9.ADT Biotech Sdn Bhd
    • 13.1. bioMérieux SA
    • 13.11.Neuberg Diagnostics
    • 13.12.Luminex Corporation
    • 13.13.Quidel Corporation
    • 13.14.ALDATU BIOSCIENCES
    • 13.15.Danaher
    • 13.16.Mylab Discovery Sulutions Pvt. Ltd.
    • 13.17.Quest Diagnostics
    • 13.18.altona Diagnostics GmbH
    • 13.19.Abbott

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 5 Porter’s Five Forces Analysis for Global COVID-19 Diagnostics Market
FIG. 6 Global COVID-19 Diagnostics Market Attractiveness, By Product
FIG. 7 Global COVID-19 Diagnostics Market Attractiveness, By Technology
FIG. 8 Global COVID-19 Diagnostics Market Attractiveness, By Test Type
FIG. 9 Global COVID-19 Diagnostics Market Attractiveness, By Mode
FIG. 10 Global COVID-19 Diagnostics Market Attractiveness, By End-User
FIG. 11 Global COVID-19 Diagnostics Market Attractiveness, By Region
FIG. 12 Company Share Analysis, 2019
FIG. 13 Global COVID-19 Diagnostics Market Revenue Share, by Product, 2019 & 2026
FIG. 14 Global COVID-19 Diagnostics Market for Instruments, Revenue (USD Billion) 2016 - 2026
FIG. 15 Global COVID-19 Diagnostics Market for Kits & Reagents, Revenue (USD Billion) 2016 – 2026
FIG. 16 Global COVID-19 Diagnostics Market for Diagnostic Services, Revenue (USD Billion) 2016 - 2026
FIG. 17 Global COVID-19 Diagnostics Market Revenue Share, by Technology, 2019 & 2026
FIG. 18 Global COVID-19 Diagnostics Market for Molecular assay, Revenue (USD Billion) 2016 - 2026
FIG. 19 Global COVID-19 Diagnostics Market for Immunological assay, Revenue (USD Billion) 2016 - 2026
FIG. 20 Global COVID-19 Diagnostics Market for Digital PCR (dPCR), Revenue (USD Billion) 2016 – 2026
FIG. 21 Global COVID-19 Diagnostics Market for Clustered regularly interspaced short palindromic repeats (CRISPR), Revenue (USD Billion) 2016 – 2026
FIG. 22 Global COVID-19 Diagnostics Market for Microarray, Revenue (USD Billion) 2016 – 2026
FIG. 23 Global COVID-19 Diagnostics Market Revenue Share, by Test Type, 2019 & 2026
FIG. 24 Global COVID-19 Diagnostics Market for Antigen-based Testing, Revenue (USD Billion) 2016 - 2026
FIG. 25 Global COVID-19 Diagnostics Market for Antibody (Serology) Testing, Revenue (USD Billion) 2016 – 2026
FIG. 26 Global COVID-19 Diagnostics Market for Molecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
FIG. 27 Global COVID-19 Diagnostics Market for Others, Revenue (USD Billion) 2016 – 2026
FIG. 28 Global COVID-19 Diagnostics Market Revenue Share, by Mode, 2019 & 2026
FIG. 29 Global COVID-19 Diagnostics Market for Point-of-Care (PoC), Revenue (USD Billion) 2016 - 2026
FIG. 30 Global COVID-19 Diagnostics Market for Non-Point-of-Care (Non-PoC), Revenue (USD Billion) 2016 – 2026
FIG. 31 Global COVID-19 Diagnostics Market Revenue Share, by End-User, 2019 & 2026
FIG. 32 Global COVID-19 Diagnostics Market for Hospitals, Revenue (USD Billion) 2016 - 2026
FIG. 33 Global COVID-19 Diagnostics Market for Diagnostic Labs & Clinics, Revenue (USD Billion) 2016 – 2026
FIG. 34 Global COVID-19 Diagnostics Market for Healthcare Labs & Clinics, Revenue (USD Billion) 2016 - 2026
FIG. 35 Global COVID-19 Diagnostics Market Revenue Share, by Region, 2019 & 2026
FIG. 36 North America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 37 Europe COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 38 Asia Pacific COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 39 Latin America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 40 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
 


Table Of Tables

List of Tables

TABLE 1 Global COVID-19 Diagnostics Market: Snapshot
TABLE 2 Drivers of the COVID-19 Diagnostics Market: Impact Analysis
TABLE 3 Restraints for the COVID-19 Diagnostics Market: Impact Analysis
TABLE 4 Global COVID-19 Diagnostics Market Revenue, by Region, 2016 – 2026 (USD Billion)
TABLE 5 North America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 6 North America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 7 North America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 8 North America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 9 North America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 10 North America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 11 Europe COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 12 Europe COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 13 Europe COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 14 Europe COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 15 Europe COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 16 Europe COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 17 Asia Pacific COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 18 Asia Pacific COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 19 Asia Pacific COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 20 Asia Pacific COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 21 Asia Pacific COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 22 Asia Pacific COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 23 Latin America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 24 Latin America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 25 Latin America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 26 Latin America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 27 Latin America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 28 Latin America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 29 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 30 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 31 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 32 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 33 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 34 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)

Methodology

FrequentlyAsked Questions

COVID-19 diagnostics are tests used to detect coronavirus infection. They support disease detection and monitoring
The global COVID-19 Diagnostics market is expected to be driven by the continued testing needs, surveillance programs, and variant detection. Demand for rapid and accurate diagnostic solutions supports expansion.
According to study, the global COVID-19 Diagnostics market size was worth around USD 52.56 Billion in 2019 and is predicted to grow to around USD 145.48 Billion By 2026.
The global COVID-19 Diagnostics market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 15.65% during the forecast period from 2020-2026.
The global COVID-19 Diagnostics industry is projected to be challenged by Challenges include declining test demand post-pandemic and pricing pressure.
The Opportunities include surveillance testing, variant detection, rapid diagnostics platforms, and preparedness for future outbreaks will offer significant growth opportunities in the COVID-19 Diagnostics market.
Rapid and multiplex testing solutions; point-of-care diagnostics; integration with digital health reporting systems are the emerging trends and innovations impacting the COVID-19 Diagnostics market.
The global COVID-19 Diagnostics market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global COVID-19 Diagnostics market are; Hologic Inc., Perkin Elmer, Inc., Veredus Laboratories, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., 1drop Inc., Laboratory Corporation of America Holdings, ADT Biotech Sdn Bhd, bioMérieux SA, Neuberg Diagnostics, Luminex Corporation, Quidel Corporation, ALDATU BIOSCIENCES, Danaher, Mylab Discovery Solutions Pvt. Ltd., Quest Diagnostics, altona Diagnostics GmbH and Abbott among others. and others.
The report explores crucial aspects of the COVID-19 Diagnostics market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

OverviewGrowth FactorsGlobalCOVID-19 DiagnosticsSegmentationGlobalCOVID-19 DiagnosticsMarket:Regional AnalysisReport Scope :GlobalCOVID-19 DiagnosticsCompetitive PlayersGlobalCOVID-19 DiagnosticsRegional Segment Analysis

HappyClients